Ketamine-Assisted EMDR™ (KA-EMDR)
Core Mechanism
Standard 8-phase EMDR protocol adapted for ketamine integration. Client self-administers low-dose sublingual ketamine (troches) at a strategically timed point during the reprocessing phases. The psycholytic dose is intended to expand the window of tolerance and enhance neuroplasticity while preserving the client's capacity to engage in bilateral stimulation and verbal processing, unlike higher-dose psychedelic approaches that impair interactive participation.
Ontology
Traumatic memories are stored in maladaptive neural networks (per EMDR's Adaptive Information Processing model). Low-dose ketamine enhances neuroplasticity and the memory reconsolidation window, allowing EMDR's bilateral stimulation to reprocess traumatic material more effectively. The pharmacological and psychotherapeutic mechanisms are proposed as synergistic rather than additive.
Therapeutic Voice
"The dose is low on purpose. You should still be able to talk to me and follow the tapping, and if it gets to be too much we stop the set and stay with the breathing until you're back."
View of the Person
The person carries unprocessed traumatic material in maladaptive neural networks. The wager is that pharmacologically widened plasticity plus EMDR's structured reprocessing does more than either component alone. That is the claim under test, not a finding the current evidence can carry.
Evidence
1 pilot study (Topel & Ciccone, 2025)
Pilot study published in European Journal of Psychotraumatology (2025) showed statistically and clinically significant reductions in PTSD symptoms and functional impairment. No RCTs yet. Evidence base is very early but published in a legitimate peer-reviewed trauma journal.
Conditions
Epistemology
Blind Spots
Rests on a single uncontrolled pilot study with no comparator, run by the modality's own developers; requires the client to self-administer a Schedule III dissociative anesthetic mid-session rather than have it clinician-administered; the protocol name is trademarked and taught only through the founders' own institute, the same training-revenue structure flagged elsewhere on this site; combines two modalities, ketamine and EMDR's bilateral stimulation, whose interaction has not been independently studied, so the claimed synergy between pharmacological and psychotherapeutic mechanisms is a hypothesis, not a finding
Contraindications
Union of the contraindications for both components, since this protocol combines them. From the ketamine side: active psychosis or psychotic spectrum disorders, uncontrolled hypertension, history of intracranial hypertension, untreated bipolar disorder, active substance use disorder (ketamine has its own misuse liability), pregnancy, and any cardiovascular or airway condition that has not been medically cleared. From the EMDR side: unstable dissociative disorders without prior stabilization, active suicidality, ongoing domestic violence without a safety plan, and seizure disorders pending clearance. Specific to this protocol: because the client self-administers sublingual ketamine, it is contraindicated wherever unsupervised access to a dissociative anesthetic is unsafe, including prior ketamine misuse, an unsafe home environment, or absence of a sober attendant. Prescribing and medical monitoring sit with a licensed prescriber, not the therapist.
Training
Licensed or pre-licensed mental health professionals with EMDRIA-approved basic EMDR training
Ketamine Assisted EMDR Therapy Institute certification (intro course + experiential training + consultation)
~6 hrs intro course + experiential training + 2-3 hrs consultation
$350 intro course + consultation fees
Philosophical Roots
Inherits EMDR's basis in information processing theory and memory reconsolidation science. The ketamine component draws on psycholytic therapy tradition (Passie et al., 2022): the use of sub-psychedelic doses to enhance psychotherapeutic process rather than induce altered states as the primary intervention.
Related Modalities
Controversies & Ethical Concerns
Very early evidence base: one pilot study. Small institute founded in 2024. Requires medical collaboration for ketamine prescribing.
Test Yourself
What distinguishes Ketamine-Assisted EMDR from standard KAP?
Show answer
KA-EMDR uses psycholytic (low) doses of sublingual ketamine specifically during EMDR reprocessing phases, preserving client engagement and emotional access rather than inducing dissociative or psychedelic states.